Proven Results

Proven Results That Accelerate Clinical Research

Our technology platform has demonstrated 94% faster enrollment timelines, 75% reduced screen failures, and 85% patient retention across 200+ clinical trials.

94%

Faster Enrollment

75%

Reduced Failures

85%

Patient Retention

200+

Trials Supported

PLATFORM IMPACT

10K+

Patients Successfully Enrolled

200+

Clinical Trials Supported

50+

Research Site Partners

94%

Faster Enrollment Timelines

(vs. traditional methods)

75%

Reduced Screen Failure Rates

85%

Patient Retention Through Study Completion

MIN

Minutes Average Patient Contact Time

(Not Days)

CASE STUDIES

Real results from real clinical trials

Case Study #1

ONCOLOGY TRIAL RESCUE

Phase II Breast Cancer Trial — Behind Timeline, At Risk of Cancellation

⚠ The Challenge

8 months behind enrollment timeline

Only 23 patients enrolled (target: 200)

$4.8M in delay penalties accumulating

Sites had exhausted patient databases

Sponsor considering trial cancellation

✓ Our Solution

Digital campaigns: Targeted Facebook, Instagram, and Google campaigns reaching breast cancer patient communities

Pre-screening: In-house team qualified every patient against protocol before site referral

Site coordination: Managed referrals across 12 sites in 6 states

Real-time analytics: Sponsor dashboard showed enrollment progress daily

★ The Results

147 patients enrolled in 4 months (vs. 23 in previous 8 months)

Screen failure rate: 12% (vs. 48% before our involvement)

$2.1M saved in avoided delay penalties

Trial completed 3 months ahead of revised timeline

"Clinical Trial Solutions saved this trial. We went from considering cancellation to finishing early."

— Sponsor Project Director

Case Study #2

FDA DIVERSITY MANDATE COMPLIANCE

Phase III Cardiovascular Trial — Hispanic Enrollment Required for Regulatory Approval

The Challenge

• Required 40% Hispanic enrollment per FDA mandate

• Current enrollment only 12% Hispanic

• Sites lacked Hispanic patient access

• Regulatory approval at stake

✓

Our Solution

Spanish-language campaigns: Full Spanish creative across Texas, Florida, California, and Puerto Rico

Bilingual pre-screening: Native Spanish-speaking coordinators for all patient calls

Community partnerships: Outreach through Hispanic health organizations and churches

Demographic documentation: Detailed tracking and reporting for FDA submission

★ The Results

12%→44%

Hispanic Enrollment

6 wks

Early Completion

100%

FDA Requirements Met

Zero

Regulatory Delays

"Clinical Trial Solutions not only met our diversity requirement—they exceeded it. Their bilingual capabilities are the real deal."

— CRO Diversity Lead

Case Study #3

RARE DISEASE RECRUITMENT

Phase I/II Genetic Disorder Trial — Ultra-Rare Population (<3,000 US Patients)

The Challenge

• Only ~3,000 diagnosed patients in entire US

• Needed 25 patients to meet enrollment

• Previous vendor failed to enroll a single patient in 6 months

• Complex eligibility with genetic confirmation required

Our Solution

Lookalike modeling: Built custom audience based on condition-specific online behaviors

Advocacy partnerships: Direct outreach through patient advocacy organizations

Nationwide reach: Telemedicine pre-screening removed geographic barriers

High-touch coordination: Dedicated coordinator for each patient given complex eligibility

The Results

28 patients enrolled (exceeding 25-patient target)

40% lower cost-per-patient vs. industry benchmark for rare diseases

Enrollment completed in 5 months (vs. 18-month original projection)

Zero dropout during treatment phase

Case Study #4

CNS/NEUROLOGY

MULTI-SITE COORDINATION

Phase III Alzheimer's Trial — Complex Screening, High Dropout Risk

The Challenge

Industry-leading 70%+ screen failure rate for AD trials. Caregiver involvement required—double the coordination. 20 sites nationwide with inconsistent performance. Previous 35% dropout rate threatening data integrity.

Our Solution

Caregiver-focused campaigns: Targeted adult children researching parent's condition. Extended pre-screening: 45-minute calls including cognitive pre-assessment. Dual coordination: Separate scheduling for patient and caregiver. Retention program: Weekly check-ins with both patient and caregiver.

38%

Screen Failure

(vs. industry 70%+)

12%

Dropout Rate

(vs. previous 35%)

100%

Timeline Met

(first time in portfolio)

9.2/10

Site Rating

(average satisfaction)

Case Study #5

VACCINE TRIAL RAPID ENROLLMENT

Phase III Respiratory Vaccine — Urgent Timeline, High-Volume Requirement

Deadline

90 Days

The Challenge

• 500 patients needed in 90 days

• Specific age and health criteria

• Seasonal urgency—enrollment window closing

• Competitive landscape—multiple similar trials recruiting

✓

Our Solution

High-volume campaigns: Scaled digital advertising to reach 2M+ impressions/week

Expanded call center: Added capacity to handle 500+ pre-screens/week

Site load balancing: Automated routing to sites with availability

Same-week scheduling: Patients scheduled within 72 hours of qualification

★

The Results

523 patients enrolled in 87 days

Seasonal window met with 3 days to spare

14% screen failure rate

Cost-per-enrolled 22% below budget

THERAPEUTIC AREAS

Our platform has successfully recruited patients across all major therapeutic areas:

🎗️

Oncology

Breast, lung, prostate, melanoma, colorectal, leukemia, lymphoma, pancreatic, ovarian, brain tumors

❤️

Cardiovascular

Heart failure, hypertension, AFib, CAD, PAD, stroke prevention

🧠

Neurology/CNS

Alzheimer's, Parkinson's, MS, epilepsy, migraine, ALS, neuropathy

⚖️

Endocrinology

Type 1 & 2 diabetes, obesity, thyroid, NASH/NAFLD

🫁

Respiratory

Asthma, COPD, cystic fibrosis, pulmonary fibrosis

🧘

Mental Health

Depression, anxiety, PTSD, bipolar, schizophrenia, OCD, ADHD

✨

Dermatology

Psoriasis, eczema, vitiligo, acne, HS

🩺

Gastrointestinal

Crohn's, ulcerative colitis, IBS, GERD, celiac

🧬

Rare Diseases

Genetic disorders, metabolic storage diseases, ultra-orphan conditions

💉

Vaccines

Respiratory, travel, HIV, hepatitis, infectious disease

Ready to See These Results on Your Trial?

Let's discuss how our platform can accelerate your enrollment timeline.

Request a Consultation